Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
Consumer OTC Drugs

Adams Not Phlegmatic About Growth, Will Hawk Mr. Mucus Overseas in 2007

This article was originally published in The Tan Sheet

  • News

Executive Summary

Adams Respiratory Therapeutics plans to expand into international sales through partnerships in fiscal 2007, according to an Aug. 24 analysts call
Table

View full table

Advertisement

Related Content

Pink Sheet
Reckitt Benckiser Looks Overseas To Double Adams’ Revenue
Pink Sheet
Reckitt Benckiser Looks Overseas To Double Adams’ Revenue
HBW Insight
Reckitt Benckiser Looks Overseas To Double Adams’ Revenue
Pink Sheet
Adams Expands OTC Cough Market Presence With Delsym Acquisition
Pink Sheet
Adams Expands OTC Cough Market Presence With Delsym Acquisition
Pink Sheet
Adams Develops New Guaifenesin Products As Mucinex Growth Continues

Topics

Advertisement
Tags:
Consumer OTC Drugs
UsernamePublicRestriction

Register

PS099688

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By